Details of the Drug

General Information of Drug (ID: DMOF322)

Drug Name

JNJ-80038114

Synonyms

JNJ-8114

Indication

Disease Entry	ICD 11	Status	REF
Prostate cancer	2C82.0	Phase 1	[1]
------------------------------------------------------------------------------------

Cross-matching ID

References

1	ClinicalTrials.gov (NCT05441501) A Phase 1 Study of JNJ-80038114, a T-Cell Redirecting Agent Targeting Prostate Specific Membrane Antigen (PSMA), for Advanced Stage Prostate Cancer. U.S.National Institutes of Health.